Companies: 10,795·Total market cap: $144.5T
Cannabis Strategic Ventures

Cannabis Strategic Ventures

NUGSOTCHealthcare● Active
$0.00
+$0.00(+30.00%)
Market Cap$243864
P/E Ratio
52W High$0.005
52W Low$0.0001
Overview

Cannabis Strategic Ventures (NUGS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NUGS · as of Jun 9, 2026

Key Statistics

EPS (TTM)nugs eps ttm · nugs earnings per shareEarnings history
PE Ratio (TTM)nugs pe ratio ttm · nugs price to earningsPE Ratio deep dive
Revenue (TTM)nugs revenue ttm · nugs annual revenueFull revenue history
Dividend YieldNo Dividenddoes nugs pay dividends · nugs dividend yieldDividend history
Shares Outstandingnugs shares outstanding · nugs floatShares outstanding history
Next EarningsTBAnugs earnings date · nugs next earningsEarnings history

About Cannabis Strategic Ventures

CEOSimon Yu
IPO DateJul 24, 2009
Employees30
CountryUS

Cannabis Strategic Ventures specializes in cultivating cannabis products across the United States. Beyond its growing operations, the firm actively fosters new ventures, expands existing operations, a…

what is cannabis strategic ventures · nugs stock overview · cannabis strategic ventures company profile · who is cannabis strategic ventures ceo · nugs OTC · cannabis strategic ventures headquarters · cannabis strategic ventures business segments

About Stock Overview & Key Data

Cannabis Strategic Ventures (NUGS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jul 24, 2009. As of the latest trading session, NUGS stock price is $0.00, with a market capitalization of $243,864. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Cannabis Strategic Ventures (NUGS) stock price is $0.00. The stock is traded on OTC under the ticker symbol NUGS. The 52-week range is $0.00 – $0.01.

NUGS stock priceNUGS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice